Osmotica Pharmaceutical is a fully-integrated pharmaceutical company with demonstrated expertise in developing commercially successful products. As one of the world's leading osmotic drug delivery companies, we leverage our significant resources in R&D and proprietary drug delivery technology to address the growing need of the global patient population.
We have the resources and experience to successfully commercialize our products through our subsidiaries, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC.
For more company information, please visit our websites:
www.Osmotica.com
www.VerticalPharma.com
www.TrigenLab.com
Location: United States, New Jersey
Employees: 201-500
Founded date: 2000
Investors 1
Date | Name | Website |
23.01.2022 | Avista Cap... | avistacap.... |
Mentions in press and media 10
Date | Title | Description | Source |
13.10.2021 | Osmotica Pharmaceuticals : plc Announces Closing of $35 Mill... | BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“O... | marketscre... |
13.10.2021 | Osmotica Pharmaceuticals plc Announces Closing of $35 Millio... | BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“O... | globenewsw... |
13.10.2021 | Osmotica Pharmaceuticals plc Announces Closing of $35 Millio... | BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“O... | marketscre... |
07.10.2021 | Osmotica Pharmaceuticals : Announces Debt Financing from Ath... | BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“O... | marketscre... |
07.10.2021 | Osmotica Pharmaceuticals plc Announces Debt Financing from A... | BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“O... | globenewsw... |
07.10.2021 | Osmotica Pharmaceuticals Announces Pricing of $35 Million Un... | BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“O... | globenewsw... |
07.10.2021 | Osmotica Pharmaceuticals : Announces Pricing of $35 Million ... | BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“O... | marketscre... |
19.02.2018 | FDA Approves Osmotica Pharmaceutical’s Once-Daily OSMOLEX ER... | Bridgewater, NJ – February 19, 2018 – Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), ... | avistacap.... |
04.12.2015 | Vertical / Trigen Holdings, LLC and Osmotica Holdings Corp L... | SAYREVILLE, N.J. and MARIETTA, GA., December 4, 2015 – Vertical / Trigen Holdings, LLC (“Vertical / ... | avistacap.... |
- | Osmotica Pharmaceuticals plc Announces Positive Topline Resu... | May 6, 2019 at 4:30 PM EDT –Second Phase III Study 202 Meets Primary Endpoint; Provides Additional ... | avistacap.... |